107 related articles for article (PubMed ID: 8764100)
1. BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner.
Chen Y; Farmer AA; Chen CF; Jones DC; Chen PL; Lee WH
Cancer Res; 1996 Jul; 56(14):3168-72. PubMed ID: 8764100
[TBL] [Abstract][Full Text] [Related]
2. BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases.
Wang H; Shao N; Ding QM; Cui J; Reddy ES; Rao VN
Oncogene; 1997 Jul; 15(2):143-57. PubMed ID: 9244350
[TBL] [Abstract][Full Text] [Related]
3. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators.
Morris L; Allen KE; La Thangue NB
Nat Cell Biol; 2000 Apr; 2(4):232-9. PubMed ID: 10783242
[TBL] [Abstract][Full Text] [Related]
4. The BRCT domain is a phospho-protein binding domain.
Yu X; Chini CC; He M; Mer G; Chen J
Science; 2003 Oct; 302(5645):639-42. PubMed ID: 14576433
[TBL] [Abstract][Full Text] [Related]
5. Herpes simplex virus type 1 infection imposes a G(1)/S block in asynchronously growing cells and prevents G(1) entry in quiescent cells.
Ehmann GL; McLean TI; Bachenheimer SL
Virology; 2000 Feb; 267(2):335-49. PubMed ID: 10662629
[TBL] [Abstract][Full Text] [Related]
6. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
7. Lovastatin induction of cyclin-dependent kinase inhibitors in human breast cells occurs in a cell cycle-independent fashion.
Gray-Bablin J; Rao S; Keyomarsi K
Cancer Res; 1997 Feb; 57(4):604-9. PubMed ID: 9044834
[TBL] [Abstract][Full Text] [Related]
8. Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1.
Somasundaram K; Zhang H; Zeng YX; Houvras Y; Peng Y; Zhang H; Wu GS; Licht JD; Weber BL; El-Deiry WS
Nature; 1997 Sep; 389(6647):187-90. PubMed ID: 9296497
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid inhibition of cell cycle progression in MCF-7 human breast cancer cells.
Zhu WY; Jones CS; Kiss A; Matsukuma K; Amin S; De Luca LM
Exp Cell Res; 1997 Aug; 234(2):293-9. PubMed ID: 9260897
[TBL] [Abstract][Full Text] [Related]
10. Cell cycle regulation of the BRCA1/acetyl-CoA-carboxylase complex.
Ray H; Suau F; Vincent A; Dalla Venezia N
Biochem Biophys Res Commun; 2009 Jan; 378(3):615-9. PubMed ID: 19061860
[TBL] [Abstract][Full Text] [Related]
11. AP-1 blockade in breast cancer cells causes cell cycle arrest by suppressing G1 cyclin expression and reducing cyclin-dependent kinase activity.
Liu Y; Lu C; Shen Q; Munoz-Medellin D; Kim H; Brown PH
Oncogene; 2004 Oct; 23(50):8238-46. PubMed ID: 15378019
[TBL] [Abstract][Full Text] [Related]
12. The amino terminus of the retinoblastoma (Rb) protein associates with a cyclin-dependent kinase-like kinase via Rb amino acids required for growth suppression.
Sterner JM; Tao Y; Kennett SB; Kim HG; Horowitz JM
Cell Growth Differ; 1996 Jan; 7(1):53-64. PubMed ID: 8788033
[TBL] [Abstract][Full Text] [Related]
13. Cyclin E dependent kinase activity in human breast cancer in relation to cyclin E, p27 and p21 expression and retinoblastoma protein phosphorylation.
Lodén M; Nielsen NH; Roos G; Emdin SO; Landberg G
Oncogene; 1999 Apr; 18(16):2557-66. PubMed ID: 10353599
[TBL] [Abstract][Full Text] [Related]
14. BRCA1 is a cell cycle-regulated nuclear phosphoprotein.
Ruffner H; Verma IM
Proc Natl Acad Sci U S A; 1997 Jul; 94(14):7138-43. PubMed ID: 9207057
[TBL] [Abstract][Full Text] [Related]
15. BRCA1 phosphorylation: biological consequences.
Ouchi T
Cancer Biol Ther; 2006 May; 5(5):470-5. PubMed ID: 16721040
[TBL] [Abstract][Full Text] [Related]
16. [Protein phosphorylations during cell cycle].
Inagaki M; Ajiro K
Tanpakushitsu Kakusan Koso; 1989 Jul; 34(9):1215-26. PubMed ID: 2798919
[No Abstract] [Full Text] [Related]
17. BRCA1 the Versatile Defender: Molecular to Environmental Perspectives.
Zhong AX; Chen Y; Chen PL
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762577
[TBL] [Abstract][Full Text] [Related]
18. A transcription-independent mechanism determines rapid periodic fluctuations of BRCA1 expression.
Nie C; Zhou XA; Zhou J; Liu Z; Gu Y; Liu W; Zhan J; Li S; Xiong Y; Zhou M; Shen Q; Wang W; Yang E; Wang J
EMBO J; 2023 Aug; 42(15):e111951. PubMed ID: 37334492
[TBL] [Abstract][Full Text] [Related]
19.
Devico Marciano N; Kroening G; Dayyani F; Zell JA; Lee FC; Cho M; Valerin JG
Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626055
[TBL] [Abstract][Full Text] [Related]
20. BRCA1 and Breast Cancer: Molecular Mechanisms and Therapeutic Strategies.
Fu X; Tan W; Song Q; Pei H; Li J
Front Cell Dev Biol; 2022; 10():813457. PubMed ID: 35300412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
